Lemaitre Vascular (LMAT) Net Cash Flow (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Net Cash Flow data on file, last reported at -$1.2 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$1.2 million, down 139.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 189.68% YoY), and the FY2025 annual result was $1.8 million, down 15.95% from the prior year.
• Net Cash Flow fell to -$1.2 million in Q1 2026 per LMAT's latest filing, from $2.7 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $5.8 million in Q4 2023 and troughed at -$4.2 million in Q2 2024.
• A 5-year average of $782764.7 and a median of $1.2 million in 2025 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow surged 378.38% in 2022, then tumbled 253.58% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $1.6 million in 2022, then soared by 273.41% to $5.8 million in 2023, then dropped by 7.38% to $5.4 million in 2024, then plunged by 48.89% to $2.7 million in 2025, then tumbled by 145.43% to -$1.2 million in 2026.
• Business Quant data shows LMAT's Net Cash Flow at -$1.2 million in Q1 2026, $2.7 million in Q4 2025, and -$1.6 million in Q3 2025.